Tricuspidal Valve Endocarditis Due to Yersinia enterocolitica
Yersinia enterocolitica is a gram-negative coccobacillus acquired by humans via oral route. It is associated with a wide spectrum of clinical and immunological manifestations, responsible for digestive diseases, including enterocolitis and mesenteric adenitis, as well as extra-digestive manifestations including respiratory tract and urinary tract infection, osteo-articular infection, erythema nodosum and endocarditis [1] . Bacteremia and sepsis are most often reported in patients with predisposing underlying disease, such as an iron-overloaded state (haemochromatosis, acute iron poisoning), immunosuppressive therapy, diabetes mellitus, alcoholism, cirrhosis or malnutrition. It is associated with a high mortality of 25-50% [2] . Infective endocarditis (IE) is a rare manifestation of Y. enterocolitica infection. Only 15 cases of Y. enterocolitica endocarditis have been published so far.
A 75-year-old man was admitted to our hospital because of high fever accompanied by chills and rigors that lasted for 7 days before admission. On the second day of high fever he felt pain and swelling of the left lower leg. The patient was in his usual state of health except for a medical history of arterial hypertension treated with amlodipine and cilazapril. A history of eating imported fish from Norway was recorded. On clinical examination his temperature was 38.2 °C, blood pressure 160/90 mmHg, and his pulse rate was 106 beats/min. The heart rhythm was regular and a grade 3/6 holosystolic ejection murmur was heard at the apex. Left lower leg and foot were edematous and Homan's sign was positive. The patient felt no pain in the abdomen. Hematocrit was 48%, leukocytes 20,900 per mm 3 with 91% neutrophils, platelets 199,000 per mm 3 , ESR 74 mm/h and urine analysis was normal. Glucose levels were normal. Total bilirubin was 42.8 μmol/l (direct 20.2; indirect 22.6), SGOT 72 U/L, SGPT 169 U/L, y-GT 328 and alkaline phosphatase 372 U/L. The chest X-ray was normal. Electrocardiogram suggested left atrium and left ventricle hypertrophy. Ultrasound examination revealed multiple gallstones and calculosis of both kidneys. Three sets of blood cultures were taken and therapy with amoxicillin/clavulanic acid 1.2 g q8h IV plus gentamicin 240 mg once daily was initiated. Stool culture was negative but it was done on MacConkey and XLD agars only. All blood cultures (BacT/ALERT FN and BacT/ALERT FA) were positive for Y. enterocolitica, serotype O:3. Current NC-CLS (CLSI) guidelines were used for sensitivity testing. E-test (AB Biodisk) was used for MIC determination. The strain was susceptible to co-amoxiclav (MIC 0.19 μg/ml), cephalotin (MIC 8.0 μg/ml), cefuroxime (MIC 1.5 μg/ml), ceftriaxone (MIC 0.047 μg/ml), imipenem (MIC 0.047 μg/ ml), amikacin (MIC 1.5 μg/ml), netilmicin (MIC 0.75 μg/ ml), gentamicin (MIC 0.75 μg/ml), ciprofloxacin (MIC 0.012 μg/ml), trimethoprim sulfamethoxazole, piperacillin, cefoperazone and intermediately sensitive to ampicillin (MIC 16.0 μg/ml). Y. enterocolitica is a rare cause of infective endocarditis. Among 1,779 patients with IE included in the International Collaboration on Endocarditis -Prospective Cohort Study [3] this is the only case of Yersinia endocarditis (R. Correy, personal communication). This is the first case of any native tricuspidal valve involvement without previously implanted pacemaker or known valvular disease and concomitant septic phlebitis. Only one patient had previously been reported with tricuspidal valve endocarditis but it was associated with contamination of previously implanted pacemaker [4] . Except for age, no other predisposing factors for Yersinia bacteremia were present in our patient. We assume that deep septic phlebitis is a consequence of gut-origin septicaemia with Y. enterocolitica. Right-side endocarditis suggests that septic phlebitis was primary infection. Conservative treatment with ampicillin and subsequent ciprofloxacin was successful and there was no need for valvular replacement. Concomitant treatment included heparin followed by warfarin for deep venous thrombosis.
Available data on 12 of 15 previously reported patients with yersinial IE are presented in table 1. Acute presentation affecting the mitral valve was recorded in three patients, aortic valve in two patients or both valves in one patient. Native valve endocarditis dominated with only two cases of prosthetic valve endocarditis. Multiple blood cultures were positive in all patients. Three patients died of septicemia and one of them had liver failure. All three patients had mitral valve vegetations and autopsies confirmed the presence of valve vegetations.
The possibility of endocarditis should be taken into account in all patients with several positive blood cultures. Similar cases were reported by Appelbaum et al. [5] and Karachalios et al. [6] . Most of the published studies report that endocarditis due to Y. enterocolitica was treated with β-lactams and/or aminoglycosides [7, 8] . Our patient was successfully treated with a combination of ampicillin and gentamicin but because of an adverse event, the therapy was changed to ciprofloxacin as a single antibiotic regimen.
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